Nemaura Medical to Conduct Shareholder Update Call April 28, 2021, 4:30PM ET
21 avr. 2021 08h10 HE
|
Nemaura Medical, Inc
Loughborough, England, April 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs
15 avr. 2021 08h07 HE
|
Nemaura Medical, Inc
Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors
13 avr. 2021 08h05 HE
|
Nemaura Medical, Inc
Loughborough, England, April 13, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board
25 mars 2021 08h10 HE
|
Nemaura Medical, Inc
Loughborough, England, March 25, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device
11 mars 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
10 mars 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, March 10, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy
04 mars 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference
02 mars 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
16 févr. 2021 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Secures $20 Million Non-Dilutive Loan to Accelerate Business Growth
11 févr. 2021 08h45 HE
|
Nemaura Medical, Inc
Loughborough, England, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...